Cipla Limited (NSE:CIPLA)
1,498.30
-15.00 (-0.99%)
Oct 8, 2025, 12:31 PM IST
Cipla Revenue
Cipla had revenue of 68.37B INR in the quarter ending June 30, 2025, with 3.20% growth. This brings the company's revenue in the last twelve months to 274.80B, up 6.13% year-over-year. In the fiscal year ending March 31, 2025, Cipla had annual revenue of 272.67B with 6.78% growth.
Revenue (ttm)
274.80B
Revenue Growth
+6.13%
P/S Ratio
4.45
Revenue / Employee
9.07M
Employees
30,313
Market Cap
1,222.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 272.67B | 17.31B | 6.78% |
Mar 31, 2024 | 255.37B | 29.77B | 13.20% |
Mar 31, 2023 | 225.59B | 8.51B | 3.92% |
Mar 31, 2022 | 217.08B | 25.87B | 13.53% |
Mar 31, 2021 | 191.21B | 20.40B | 11.94% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Aurobindo Pharma | 320.25B |
Cipla News
- 7 days ago - Nifty top gainers today, September 30: JSW Steel, UltraTech, Adani Ports, Tata Motors, Cipla and more - Business Upturn
- 11 days ago - Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in - The Times of India
- 12 days ago - Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street - The Times of India
- 12 days ago - Indian pharma stocks in focus as Trump announces 100% tariff on branded drugs - Business Upturn
- 13 days ago - Stock market live updates today: Indian share market updates, Sensex & Nifty on 25 Sept 2025 - Business Upturn
- 15 days ago - Nifty 50 top losers today, September 22: Tech Mahindra, TCS, Infosys, Cipla, Wipro, HCL Technologies and more - Business Upturn
- 19 days ago - Nifty top gainers today, September 18: Eternal, HDFC Life, Sun Pharma, Cipla, Infosys and more - Business Upturn
- 22 days ago - Nifty 50 top losers today, September 15: Cipla, Asian Paints, Mahindra & Mahindra, Shriram Finance, Dr. Reddy’s and more - Business Upturn